search
Back to results

Collaborative Care Intervention for Cancer Patients and Their Family Caregivers -LITE (CARES-Lite)

Primary Purpose

Cancer, Depression, Fatigue

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Stepped collaborative care intervention
Enhanced Usual Care
Sponsored by
University of Pittsburgh
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Cancer focused on measuring Cancer Depression Fatigue Pain

Eligibility Criteria

21 Years - 100 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Patients: Biopsy and/or radiograph proven diagnosis of hepatocellular carcinoma, cholangiocarcinoma, gallbladder carcinoma or breast, ovarian, or colorectal cancer with liver metastases with a life expectancy of at least one year; age >21 years; no evidence of thought disorder, delusions, or active suicidal ideation is observed or reported. Caregivers: A spouse or cohabitating intimate partner of an advanced cancer patient being evaluated the UPMC's Liver Cancer Center and age >21 years Exclusion Criteria: Patients: Age < 21 years, Lack of fluency in English, Evidence of thought disorder, delusions, hallucinations, or suicidal ideation. Caregivers: Age < 21 years, Lack of fluency in English, Evidence of thought disorder, delusions, hallucinations, or suicidal ideation.

Sites / Locations

  • University of Pittsburgh Medical Center Montefiore Liver Cancer CenterRecruiting
  • University of Pittsburgh's Medical Center Montefiore HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Stepped collaborative care intervention

Enhanced Usual Care

Arm Description

The 'Stepped Collaborative Care Intervention' includes at least biweekly contact from a care coordinator by phone and face to face visits occurring approximately every 2 months, and 24 hour 7 day a week access to a website that was specifically designed during the pilot study for advanced cancer patients from socioeconomically disadvantaged backgrounds.

Patients randomized to the 'Enhanced Usual Care' arm receive their usual care from their medical team. However, if the patient scores in the clinical range on one or more of the three symptoms s/he will receive education about the symptom and be referred to the appropriate health care provider for further treatment in their community. The care coordinator will follow up with the patient after 3 weeks to assess barriers to treatment and assist further with accessing treatment if needed.

Outcomes

Primary Outcome Measures

Sleep Quality
Pittsburgh Sleep Quality Index (PSQI)
Pain Level
Brief Pain Inventory (BPI)
Functioning
Functional Assessment for Cancer Therapy Hepatobiliary (FACT - Hep)
Depression
Center for Epidemiological Studies -Depression (CESD)
Stress
Perceived Stress Scale (PSS)
Fatigue
Functional Assessment for Cancer Therapy Fatigue (FACT - Fatigue)
Caregiver Quality of Life
Caregiver Quality of Life Questionnaire (CQOL)

Secondary Outcome Measures

Full Information

First Posted
August 29, 2022
Last Updated
November 21, 2022
Sponsor
University of Pittsburgh
search

1. Study Identification

Unique Protocol Identification Number
NCT05601206
Brief Title
Collaborative Care Intervention for Cancer Patients and Their Family Caregivers -LITE
Acronym
CARES-Lite
Official Title
Collaborative Care Intervention for Cancer Patients and Their Family Caregivers -LITE
Study Type
Interventional

2. Study Status

Record Verification Date
November 2022
Overall Recruitment Status
Recruiting
Study Start Date
November 14, 2022 (Actual)
Primary Completion Date
December 15, 2024 (Anticipated)
Study Completion Date
December 1, 2027 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Pittsburgh

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
To test the efficacy of a web-based stepped collaborative care intervention to reduce symptoms of depression, pain, and fatigue and improve health-related quality of life (HRQL) in advanced cancer patients and to reduce stress and depression, and fewer CVD risk factors in caregivers.
Detailed Description
The intervention is designed to maintain quality of life for those in greatest need and least access to resources. This innovative and scalable web-based collaborative care intervention is expected not only to improve patients' quality of life, at the end of life, but also reduce caregiver stress and depression, and potentially health morbidity and mortality of patients and spousal and intimate partner caregivers from socioeconomically disadvantaged backgrounds. Study findings are expected to lead to research examining the dissemination and implementation of the intervention.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cancer, Depression, Fatigue, Pain, Sleep
Keywords
Cancer Depression Fatigue Pain

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized controlled trial
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Stepped collaborative care intervention
Arm Type
Experimental
Arm Description
The 'Stepped Collaborative Care Intervention' includes at least biweekly contact from a care coordinator by phone and face to face visits occurring approximately every 2 months, and 24 hour 7 day a week access to a website that was specifically designed during the pilot study for advanced cancer patients from socioeconomically disadvantaged backgrounds.
Arm Title
Enhanced Usual Care
Arm Type
Active Comparator
Arm Description
Patients randomized to the 'Enhanced Usual Care' arm receive their usual care from their medical team. However, if the patient scores in the clinical range on one or more of the three symptoms s/he will receive education about the symptom and be referred to the appropriate health care provider for further treatment in their community. The care coordinator will follow up with the patient after 3 weeks to assess barriers to treatment and assist further with accessing treatment if needed.
Intervention Type
Behavioral
Intervention Name(s)
Stepped collaborative care intervention
Other Intervention Name(s)
Treatment
Intervention Description
Using website that was specifically designed for advanced cancer patient, collaborative with treatment from health professional
Intervention Type
Behavioral
Intervention Name(s)
Enhanced Usual Care
Other Intervention Name(s)
Control
Intervention Description
Usual care from health providers
Primary Outcome Measure Information:
Title
Sleep Quality
Description
Pittsburgh Sleep Quality Index (PSQI)
Time Frame
Change from baseline at 6 months
Title
Pain Level
Description
Brief Pain Inventory (BPI)
Time Frame
Change from baseline at 6 months
Title
Functioning
Description
Functional Assessment for Cancer Therapy Hepatobiliary (FACT - Hep)
Time Frame
Change from baseline at 6 months
Title
Depression
Description
Center for Epidemiological Studies -Depression (CESD)
Time Frame
Change from baseline at 6 months
Title
Stress
Description
Perceived Stress Scale (PSS)
Time Frame
Change from baseline at 6 months
Title
Fatigue
Description
Functional Assessment for Cancer Therapy Fatigue (FACT - Fatigue)
Time Frame
Change from baseline at 6 months
Title
Caregiver Quality of Life
Description
Caregiver Quality of Life Questionnaire (CQOL)
Time Frame
Change from baseline at 6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Patients: Biopsy and/or radiograph proven diagnosis of hepatocellular carcinoma, cholangiocarcinoma, gallbladder carcinoma or breast, ovarian, or colorectal cancer with liver metastases with a life expectancy of at least one year; age >21 years; no evidence of thought disorder, delusions, or active suicidal ideation is observed or reported. Caregivers: A spouse or cohabitating intimate partner of an advanced cancer patient being evaluated the UPMC's Liver Cancer Center and age >21 years Exclusion Criteria: Patients: Age < 21 years, Lack of fluency in English, Evidence of thought disorder, delusions, hallucinations, or suicidal ideation. Caregivers: Age < 21 years, Lack of fluency in English, Evidence of thought disorder, delusions, hallucinations, or suicidal ideation.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jennifer L Steel, PhD
Phone
14126922041
Email
steeljl@upmc.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jennifer L Steel
Organizational Affiliation
UPMC Department of Surgery
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Pittsburgh Medical Center Montefiore Liver Cancer Center
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15213
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jennifer L Steel, PhD
Phone
412-692-2041
Email
steeljl@upmc.edu
Facility Name
University of Pittsburgh's Medical Center Montefiore Hospital
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15213
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jennifer L. Steel, PhD
Phone
412-624-3959
Email
steeljl@upmc.edu

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
De-Identified Data may be shared with investigators who request data from the Primary Investigator
IPD Sharing Time Frame
Data will be available at the end of the study for up to one year.
IPD Sharing Access Criteria
Appropriate investigator credentials (MD, PhD) and request, and for up to one year after study completion

Learn more about this trial

Collaborative Care Intervention for Cancer Patients and Their Family Caregivers -LITE

We'll reach out to this number within 24 hrs